Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system
The Prostate · 2024
DOI: 10.1002/pros.24687 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Richard Bennett und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Positron Emission Tomography Computed Tomography, Prostatic Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) provides appropriate use criteria (AUC) for prostate‐specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) which include guidance on imaging in newly diagnosed prostate cancer and in patients with biochemically recurrent (BCR) disease. This study aims to examine trends in PSMA implementation and the prevalence and outcomes of scans ordered in scenarios deemed rarely appropriate or not meeting SNMMI AUC.
Methods
We retrospectively identified patients who were diagnosed with presumptive National Comprehensive Cancer Network unfavorable intermediate, high, or very high risk prostate cancer, patients who underwent staging for BCR, and all patients staged with PSMA between July 2021 and March 2023. Positivity was validated by adherence to a predetermined reference standard.
Results
The frequency of PSMA use increased in initial staging from 24% to 80% and work‐up of BCR from 91% to 99% over our study period. In addition, 5% (17/340) of PSMA scans ordered for initial staging did not meet AUC and 3% (15/557) of posttreatment scans were deemed rarely appropriate. Initial staging orders not meeting SNMMI AUC resulted in no positivity (0/17), while rarely appropriate posttreatment scans were falsely positive in 75% (3/4) of cases. Urologists (53%, 17/32) comprised the largest ordering specialty in rarely appropriate use.
Conclusion
The frequency of PSMA use rose across the study period. A significant minority of patients received PSMA PET/CT in rarely appropriate scenarios yielding no positivity in initial staging and significant false positivity post‐therapy. Further education of providers and electronic medical record‐based interventions could help limit the rarely appropriate use of PET imaging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
- Department of Urology, Indiana University School of Medicine, Indianapolis, Indiana, USA.
- Molecular Imaging and Therapeutics, Department of Radiology, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Radiology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA.
ORCID-Profile: Richard Bennett, Jonathan A Aguiar
Zitieren
APA
Bennett, R., Li, E. V., Ho, A. Y., Aguiar, J. A., Neill, C., Rowe, S. P., Patel, H. D., Savas, H., & Ross, A. E. (2024). Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system. The Prostate. https://doi.org/10.1002/pros.24687
Vancouver
Bennett R, Li EV, Ho AY, Aguiar JA, Neill C, Rowe SP, et al. Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system. The Prostate. 2024. doi:10.1002/pros.24687
BibTeX
@article{Bennett2024,
author = {Bennett, Richard and Li, Eric V and Ho, Austin Y and Aguiar, Jonathan A and Neill, Clayton and Rowe, Steven P and Patel, Hiten D and Savas, Hatice and Ross, Ashley E},
title = {Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24687}
}
EUVIMED